LONZA GRP N (LO3 DU) stock market data APIs
€590.7147
8.01(1.4%)
as of September 23, 2026
Try our APIs with
free plan!
LONZA GRP N Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for LO3.DU.
Prev. Close
590.7147
Open
598.7221
High
601.8701
Low
587.5322
52 wk Range
494.7744-640
Market Cap
53 581 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LONZA GRP N data using free add-ons & libraries
Get LONZA GRP N Fundamental Data
LONZA GRP N Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LONZA GRP N News
New
Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and More
Company Logo Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been adde...
Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza Group
Company Logo Europe's cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturing D...
Lonza Group Ltd (LZAGF) (H1 2026) Earnings Call Highlights: Strong Growth Amid Strategic ...
This article first appeared on GuruFocus. Revenue: CHF3.4 billion, with a CER sales growth of 16% compared to H1 2025. Core EBITDA: CHF1.2 billion, representing a margin of 34.8%, an increase of 4.4 ...
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractiv...
Get LONZA GRP N fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
